SANTA BARBARA, Calif., Oct. 27, 2016 -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its third quarter 2016 financial results on Tuesday, November 8, 2016 after the market closes.
Sientra will hold a conference call on Tuesday, November 8, 2016 at 1:30 p.m. PT/4:30 p.m. ET to discuss the results. A press release disclosing the Company's financial results will be distributed at approximately 1:00 p.m. PT/4:00 p.m. ET that same day.
The dial-in numbers are (844) 464-3933 for domestic callers and (765) 507-2612 for international callers. The conference ID is 1318597. A live webcast of the conference call will be available on the Investor Relations section of the Company's website at www.sientra.com.
A replay of the call will be available starting on November 8, 2016 at 4:30 p.m. PT/7:30 p.m. ET, through November 9, 2016 at 8:59 p.m. PT/11:59 p.m. ET. To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers, and use the replay conference ID 1318597. The webcast will be available on the Investor Relations section of the Company’s website for 30 days following the completion of the call.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including bioCorneum®, the professional choice in scar management.
Investor Contacts: The Ruth Group Nick Laudico / Brian Johnston (646) 536-7030 / (646) 536-7028 [email protected]


Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
OpenAI Addresses Security Vulnerability in macOS App Certification Process
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 



